A new global survey suggests pet owners may recognize parasite risks but still need more guidance on prevention. In a March 18 press release, Boehringer Ingelheim said 43% of the ...
Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results